Clinical Trial Update: Finding the Best Dose of Aspirin to Prevent Lynch Syndrome Cancers [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the best aspirin dose to prevent Lynch syndrome–associated cancers; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Lynch Syndrome

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Lynch Syndrome I (Site-specific Colonic Cancer) | Phase 3 | Status: NOT_YET_RECRUITING